ASX:MEB

Medibio (MEB) Stock Price, News & Analysis

→ Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad)

Free MEB Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 1.26 million shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Medibio alerts:

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Medibio

Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

MEB Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive MEB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medibio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: ASX:MEB
CUSIP: N/A
CIK: N/A
Web: www.medibio.com.au
Phone: 952-222-0551
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,070,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -45.66%
Return on Assets: -13.16%

Debt

Debt-to-Equity Ratio: 1.74
Current Ratio: 0.17
Quick Ratio: 0.75

Sales & Book Value

Annual Sales: $1.01 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 3.50
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 6,100,000,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.62

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Dr. Thomas R. Young M.D.
CEO & Exec. Director
Mr. Kai Sun
Chief Operating Officer
Ms. Stephanie Ottens
Investor Relations Director
Mr. Josh Purdy
PR Director
Mr. Archie Defillo M.D.
Chief Medical Officer
Mr. Massimiliano Grassi
Head of Artificial Intelligence
Mr. Stephen Buckley
Company Sec.

Key Competitors

View All Competitors

Insiders

David Trimboli
Sold 83,333,333 shares
Total: $83,333.33 ($0.00/share)

This page (ASX:MEB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Medibio (MEB) Stock Price, News & Analysis

About Medibio

MEB Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info